Cole Peters - UC Berkeley, University of California

基本信息

浏览量：16

职业迁徙

个人简介

Cole Peters currently works at the Pediatrics department at UCLA. Cole does research in Molecular Biology, Biotechnology and Genetics. Their current project is 'Oncolytic virus and PARP inhibitors for the treatment of cancer stem cells'.

研究兴趣

论文共 53 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 3: Multiomics analyses reveal functional DNA, methylation pattern changes in clinical transgenic T-cell receptor cell therapy products

Giulia Protti,Cole Peters,Moe Kawakami, Conner Kidd, Varsha Subramanyam, Analynn Lechien, Andrew Dinh,Antoni Ribas,Matteo Pellegrini,Theodore S. Nowicki

Cancer Researchno. 6_Supplement (2024): 3-3

引用0浏览0引用

Supplemental Figure 15 from Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

Theodore S. Nowicki,Cole W. Peters,Crystal Quiros,Conner K. Kidd,Moe Kawakami,Alexandra M. Klomhaus,Ignacio Baselga-Carretero,Paula Kaplan‐Lefko,Mignonette H. Macabali,Ivan Perez Garcilazo,Beata Berent-Maoz, Begoña Comı́n-Anduix,Antoni Ribas

openalex（2023）

引用0浏览0引用

Supplemental Figure 2 from Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

Theodore S. Nowicki,Cole W. Peters,Crystal Quiros,Conner K. Kidd,Moe Kawakami,Alexandra M. Klomhaus,Ignacio Baselga-Carretero,Paula Kaplan-Lefko,Mignonette H. Macabali,Ivan Perez Garcilazo,Beata Berent-Maoz,Begoña Comin-Anduix,Antoni Ribas

crossref（2023）

引用0浏览0引用

Immunotherapy Resistance Driven by Loss of NY-ESO-1 Expression in Response to Transgenic Adoptive Cellular Therapy with PD-1 Blockade

Luke Frankiw,Arun Singh,Cole Peters, Begona Comin-Anduix,Beata Berent-Maoz,Mignonette Macabali, Kiana Shammaie,Crystal Quiros,Paula Kaplan-Lefko,Ignacio Baselga Carretero,Antoni Ribas,Theodore Scott Nowicki

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 5 (2023)

引用2浏览0WOS引用

Supplemental Figure 17 from Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

openalex（2023）

引用0浏览0引用

Supplemental Figure 16 from Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

openalex（2023）

引用0浏览0引用

Abstract 914: Preinfusion Polyfunctional Profiles and Cytokine Secretion Activity of Transgenic TCR-T Cells, and Serum Cytokine Profiles, Are Associated with Clinical Outcomes in Sarcoma and Melanoma

Cole W. Peters,Crystal Quiros, Edward X. Han,Moe Kawakami, Conner Kidd,Alexandra Klomhaus,Antoni Ribas,Theodore S. Nowicki

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Supplemental Figure 7 from Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

openalex（2023）

引用0浏览0引用

Supplementary Figure from Hypophosphatemia Due to Increased Effector Cell Metabolic Activity is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy

Jack Pengfei Tang,Cole W. Peters,Crystal Quiros, Xiaoyan Wang,Alexandra M. Klomhaus,Reiko E. Yamada,John M. Timmerman,Theodore B. Moore,Theodore S. Nowicki

crossref（2023）

引用0浏览0引用

Figure S4 from Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models

Dipongkor Saha,Hiroaki Wakimoto,Cole W. Peters,Slawomir J. Antoszczyk, Samuel D. Rabkin,Robert L. Martuza

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn